- Home
- EXEL vs OSK Comparison
EXEL vs OSK Comparison
Compare EXEL & OSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EXEL | OSK |
|---|---|---|
| Founded | 1994 | 1917 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 9.8B |
| IPO Year | 2000 | 2009 |
Fundamental Metrics
Financial Performance| Metric | EXEL | OSK |
|---|---|---|
| Price | $44.74 | $146.09 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 14 |
| Target Price | $46.50 | ★ $166.79 |
| AVG Volume (30 Days) | ★ 2.1M | 501.2K |
| Earning Date | 05-05-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 1.55% |
| EPS Growth | ★ 57.95 | N/A |
| EPS | ★ 2.78 | 1.14 |
| Revenue | $452,477,000.00 | ★ $7,705,500,000.00 |
| Revenue This Year | $13.61 | $5.94 |
| Revenue Next Year | $13.13 | $7.19 |
| P/E Ratio | ★ $16.06 | $128.43 |
| Revenue Growth | N/A | ★ 12.83 |
| 52 Week Low | $33.76 | $87.54 |
| 52 Week High | $48.74 | $180.49 |
Technical Indicators
Market Signals| Indicator | EXEL | OSK |
|---|---|---|
| Relative Strength Index (RSI) | 54.96 | 45.73 |
| Support Level | $40.98 | $137.24 |
| Resistance Level | $46.66 | $158.57 |
| Average True Range (ATR) | 1.31 | 5.60 |
| MACD | -0.08 | 0.22 |
| Stochastic Oscillator | 44.16 | 36.37 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About OSK Oshkosh Corporation
Oshkosh is a leading maker of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, including postal, firefighting, refuse/recycling collection, aviation, and construction. It is typically the market share leader or No. 2 player in North America, or even the global leader in the case of its JLG aerial work platform business. The transport segment is a leading provider of light trucks to the military and vehicles to the Postal Service. The vocational segment, featuring brands such as Pierce, AeroTech, and Volterra, offers purpose-built vehicles and equipment to municipalities. The company reports three segments—Access equipment (45% of revenue), Vocational (35%), and Transport (20%) on 2025 revenue of $10.4 billion.